Evaluating the utility of a patient decision aid for potential participants of a prostate cancer trial (RAVES-TROG 08.03)

Puma Sundaresan; Sandra Turner; Andrew Kneebone; Maria Pearse; Phyllis Butow

doi:10.1016/j.radonc.2011.07.016

Evaluating the utility of a patient decision aid for potential participants of a prostate cancer trial (RAVES-TROG 08.03)

Radiother Oncol. 2011 Dec;101(3):521-4. doi: 10.1016/j.radonc.2011.07.016. Epub 2011 Oct 8.

Authors

Puma Sundaresan¹, Sandra Turner, Andrew Kneebone, Maria Pearse, Phyllis Butow

Affiliation

¹ Department of Radiation Oncology, Royal Prince Alfred Hospital, Camperdown, Australia. puma.sundaresan@sswahs.nsw.gov.au

PMID: 21985948
DOI: 10.1016/j.radonc.2011.07.016

Abstract

Randomised controlled trials (RCTs) can be hampered by poor patient accrual and retention. Decision aids (DAs) containing simple, evidence-based information, may assist patients with decision-making regarding trial participation. The current DA was of use for 95% of participants. Further evaluation of the DA in a RCT is currently underway.

MeSH terms

Adult
Decision Support Techniques*
Humans
Male
Middle Aged
Patient Participation*
Prostatic Neoplasms / radiotherapy*
Randomized Controlled Trials as Topic*